Quoin Pharmaceuticals Ltd.

QNRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$6.90

-$0.16 (-2.27%)

At close: Sep 21, 2026, 4:00 PM ET

$7.23

+$0.33 (+4.78%)

After-hours: Sep 21, 2026, 7:34 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $14.18M

Enterprise Value $3.06M

Beta 1.66

Average Volume 233.25K

Shares Outstanding (Diluted) 2.01M

Shares Change YoY 241.47%

Institutional Ownership 60.41%

Exchange NASDAQ

ISIN US74907L4095

Price Performance

Price Change 1M 25.0%

Price Change 3M 112.3%

Price Change 6M -25.6%

Price Change YTD -51.0%

Price Change 1Y -1.6%

Price Change 3Y -95.8%

Price Change 5Y -100.0%

1M CAGR (ann.) 54.5%

1Y CAGR (ann.) -17.8%

5Y CAGR (ann.) -86.0%

All-Time CAGR -67.1%

Valuation

PE Ratio -0.49

Forward PE N/A

PEG Ratio -0.00

Forward PEG 0.01

PS Ratio N/A

Forward PS 1.10

PB Ratio 3.52

P/FCF Ratio -0.90

P/Adj. FCF Ratio -0.01

P/OCF Ratio -0.90

EV/Sales N/A

EV/EBIT -0.16

EV/EBITDA -0.16

EV/FCF -0.20

Earnings Yield -204.6%

FCF Yield -111.1%

Adj. FCF Yield -8389.2%

Financial Health

Net Cash $10.8M

Total Debt $0

Cash & Short-Term Investments $10.8M

Total Assets $11.97M

Current Ratio 1.76

Quick Ratio 1.76

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score -13.19

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -7453.4%

Returns

Return on Assets -156.7%

Return on Equity -304.9%

Return on Invested Capital -359.2%

Return on Capital Employed -359.2%

Return on Tangible Assets -161.2%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y 42.4%

EPS CAGR 3Y -20.9%

EPS CAGR 5Y 100.0%

EPS CAGR 10Y -170.9%

FCF CAGR 3Y -32.6%

FCF CAGR 5Y -18.0%

FCF CAGR 10Y -11.1%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y 37.9%

Revenue Growth Next 3Y N/A

Earnings Date Nov 4, 2026

EPS Estimate (next Q) -$1.63

EPS Growth Est (next Q) -75.7%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-15.39M

Free Cash Flow $-15.39M

Adj. Free Cash Flow $-1.16B

FCF Per Share -$7.66

OCF Per Share -$7.66

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-25.43K

Operating Income $-19.24M

EBITDA $-18.91M

Net Income $-18.76M

EPS (Diluted) -$14.12

Revenue / Employee N/A

Profit / Employee $-4.69M

Employees 4